New patent expiration for Bristol-myers drug ABRAXANE
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Bristol-myers and is included in one NDA. It […]
New patent expiration for Bristol-myers drug ABRAXANE Read Post »
Patent Expiration
New patent expiration for Harrow Eye drug ILEVRO
Annual Drug Patent Expirations for ILEVRO Ilevro is a drug marketed by Harrow Eye and is included in one NDA.
New patent expiration for Harrow Eye drug ILEVRO Read Post »
Drug Patent Expirations for the Week of June 2, 2024
ILEVRO (nepafenac) Harrow eye Patent: 7,947,295 Expiration: Jun 8, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 2, 2024 Read Post »
New patent expiration for Paratek Pharms drug NUZYRA
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two
New patent expiration for Paratek Pharms drug NUZYRA Read Post »
New patent expiration for Xspire Pharma drug ZONTIVITY
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA.
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
New patent expiration for Xspire Pharma drug ZONTIVITY
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA.
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
New patent expiration for Cephalon drug NUVIGIL
Annual Drug Patent Expirations for NUVIGIL Nuvigil is a drug marketed by Cephalon and is included in one NDA. It
New patent expiration for Cephalon drug PROVIGIL
Annual Drug Patent Expirations for PROVIGIL Provigil is a drug marketed by Cephalon and is included in one NDA. It
New patent expiration for Cephalon drug PROVIGIL Read Post »
New patent expiration for Abbvie drug ACULAR LS
Annual Drug Patent Expirations for ACULAR+LS Acular Ls is a drug marketed by Abbvie and is included in one NDA.
